{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-079321","form_type":"8-K","ticker":"CGC","cik":"0001737927","company_name":"Canopy Growth Corp","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.520539+00:00","generated_at":"2026-05-20T04:34:14.470989+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Canopy Growth Q4 revenue down 11% YoY to $65M; adjusted EBITDA loss improves 39% to $9.2M","bullets":["Net revenue $65M in Q4 FY2025, down 11% YoY; net loss from continuing ops $221.5M.","Canada medical cannabis revenue up 13% YoY; adult-use down 3%; international down 35%.","Total debt reduced 49% in FY2025 to $304M; cost savings target at least $20M annualized over 12-18 months.","Storz & Bickel revenue down 23% to $17.1M in Q4; FY2025 revenue up 4% to $73.4M.","Acreage in default; lenders forbear until June 1, 2025 while discussing potential debt extension."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-079321","json":"https://secwatch.observer/filing/0000950170-25-079321.json","markdown":"https://secwatch.observer/filing/0000950170-25-079321.md","text":"https://secwatch.observer/filing/0000950170-25-079321.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737927/000095017025079321/0000950170-25-079321-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737927/000095017025079321/cgc-20250530.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:34:14.470989+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}